Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate

Completed

Conditions studied: Fertility

In brief

The purpose of this study is to assess continuation rates and patient satisfaction with self administration subcutaneous depot medroxyprogesterone acetate.

Key facts

Study ID

NCT00770887

Run by

University of North Carolina, Chapel Hill

People needed

50

Starts

2010-05-01

Expected to finish

2011-06-01

Last updated by the study team

2011-08-11

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women 18 years or older
• Can understand written and spoken English
• Current or past user of DMPA or desires initiation of DMPA for contraception
• Provider has approved DMPA use in this woman
• Willing to consider/attempt DMPA self-injection.
• Willing to receive phone calls/letter for follow up
• Willing to return letters for follow up

You may not qualify if…

• Has contraindications to DMPA use:
• Vaginal bleeding of unknown etiology
• Medication use for Cushing's syndrome
• Currently pregnant
• Blood pressure >160/100
• Intolerance to the idea of irregular or absent menses

Where it is running

• Planned Parenthood of Southwest and Central Florida — Fort Myers, Florida, United States
• Planned Parenthood of Southwest and Central Florida — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.